BTMD Stock Summary and Trading Ideas (Biote Corp. - Class A | NASDAQ:BTMD)

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.

Biote Corp. - Class A trades on the NASDAQ stock market under the symbol BTMD.

As of January 17, 2025, BTMD stock price was flat at $5.64 with 70,459 million shares trading.

BTMD has a market cap of $175.48 million. This is considered a Micro Cap stock.

Last quarter Biote Corp. - Class A reported $51 million in Revenue and $.33 earnings per share. This beat revenue expectation by $4,000 and exceeded earnings estimates by $.24.

The top ETF exchange traded funds that BTMD belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

BTMD has underperformed the market in the last year with a price return of +21.8% while the SPY ETF gained +28.0%. However, in the short term, BTMD had mixed performance relative to the market. It has outperformed in the last 3 months, returning +6.0% vs +3.0% return in SPY. But in the last 2 weeks, BTMD shares have been beat by the market, returning -9.0% compared to an SPY return of +1.0%.

BTMD support price is $5.40 and resistance is $5.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BTMD shares will trade within this expected range on the day.